World Health Organization adds advanced diabetes drugs to its essential medicines list.

Arabian Sea Newspaper - Special

The World Health Organization adds advanced diabetes drugs to its essential list. Geneva - Arabian Sea The World Health Organization announced today the inclusion of GLP-1 drugs for the treatment of type 2 diabetes in its list of essential medicines, along with modern drugs for the treatment of major types of cancer. The decision aims to facilitate access to these drugs for low- and middle-income countries, after access to them was limited to wealthy countries due to their high prices. Strategic Insight: This step is not only about health, but also reflects a shift in the concept of global health security. The World Health Organization is sending a message to major pharmaceutical companies that the era of treatment monopoly is coming to an end. It also paves the way for new dynamics in drug manufacturing locally within developing countries, which may redraw the map of health and economic influence in the next decade.